1. Home
  2. ITOS vs TCMD Comparison

ITOS vs TCMD Comparison

Compare ITOS & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • TCMD
  • Stock Information
  • Founded
  • ITOS 2011
  • TCMD 1995
  • Country
  • ITOS United States
  • TCMD United States
  • Employees
  • ITOS N/A
  • TCMD N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • TCMD Medical/Dental Instruments
  • Sector
  • ITOS Health Care
  • TCMD Health Care
  • Exchange
  • ITOS Nasdaq
  • TCMD Nasdaq
  • Market Cap
  • ITOS 270.7M
  • TCMD 314.0M
  • IPO Year
  • ITOS 2020
  • TCMD 2016
  • Fundamental
  • Price
  • ITOS $6.67
  • TCMD $9.54
  • Analyst Decision
  • ITOS Strong Buy
  • TCMD Hold
  • Analyst Count
  • ITOS 3
  • TCMD 3
  • Target Price
  • ITOS $25.67
  • TCMD $16.00
  • AVG Volume (30 Days)
  • ITOS 550.0K
  • TCMD 312.7K
  • Earning Date
  • ITOS 04-28-2025
  • TCMD 05-05-2025
  • Dividend Yield
  • ITOS N/A
  • TCMD N/A
  • EPS Growth
  • ITOS N/A
  • TCMD N/A
  • EPS
  • ITOS N/A
  • TCMD 0.66
  • Revenue
  • ITOS $35,000,000.00
  • TCMD $293,164,000.00
  • Revenue This Year
  • ITOS N/A
  • TCMD $10.68
  • Revenue Next Year
  • ITOS $31.74
  • TCMD $8.82
  • P/E Ratio
  • ITOS N/A
  • TCMD $14.40
  • Revenue Growth
  • ITOS 177.89
  • TCMD 5.96
  • 52 Week Low
  • ITOS $4.80
  • TCMD $8.61
  • 52 Week High
  • ITOS $18.75
  • TCMD $21.10
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 49.00
  • TCMD 20.45
  • Support Level
  • ITOS $6.18
  • TCMD $8.61
  • Resistance Level
  • ITOS $7.80
  • TCMD $14.22
  • Average True Range (ATR)
  • ITOS 0.50
  • TCMD 0.48
  • MACD
  • ITOS -0.05
  • TCMD -0.51
  • Stochastic Oscillator
  • ITOS 29.94
  • TCMD 15.50

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Share on Social Networks: